Boundless Bio, Inc. (BOLD) vs eXoZymes, Inc. (EXOZ)

A side-by-side comparison of Boundless Bio, Inc. and eXoZymes, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Boundless Bio, Inc. logo
BOLD
Boundless Bio, Inc.
$58M
$2.56HealthcareDelayed quote: Oct 6, 2026, 10:54 AM EDT
eXoZymes, Inc. logo
EXOZ
eXoZymes, Inc.
$53M
$5.72HealthcareDelayed quote: Oct 6, 2026, 10:42 AM EDT

Total return — BOLD vs EXOZ

growth of $100 · dividends reinvested · last 2y
BOLD -27.2% (-14.7%/yr)EXOZ -36.2% (-20.1%/yr)BOLD compounded faster over this window
50100150200250Start $10020252026$73$64
BOLD EXOZ

BOLD vs EXOZ: by the numbers

  • •BOLD is the larger company ($58M vs $53M market cap).

Metrics side by side

Valuation

MetricBOLDEXOZ
P/B ratio0.8714.53

Profitability

MetricBOLDEXOZ
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-58.99%-278.89%
ROIC-43.97%-157.40%

Go deeper

Full BOLD analysisFull EXOZ analysisInteractive comparison tool

Dig into the metrics

Boundless Bio ROEeXoZymes ROEBoundless Bio operating margineXoZymes operating marginBoundless Bio revenue growtheXoZymes revenue growthBoundless Bio free cash floweXoZymes free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.